Ahmed Telbany MD, MPH (@telbanymd) 's Twitter Profile
Ahmed Telbany MD, MPH

@telbanymd

Gastroenterology Fellow @ The University of New Mexico @UNMSOM_GI | Associate Editor @ACGCRJ | @CAPERpancreas Scholar | Congressional Advocate @AmerGastroAssn

ID: 243411335

calendar_today27-01-2011 00:12:04

840 Tweet

832 Followers

1,1K Following

ACGCRJ (@acgcrj) 's Twitter Profile Photo

May Reviewer of the Month: Dr. Yusuf Kagzi Dr. Kagzi is recognized for submitting a high volume of reviews and earning a high reviewer rating from the #ACGCRJ editorial board. Thank you, Dr. Kagzi! Nadeem Yousaf Prateek Harne MBBS, MD ACG #GITwitter #MedTwitter

May Reviewer of the Month: 
Dr. Yusuf Kagzi

Dr. Kagzi is recognized for submitting a high volume of reviews and earning a high reviewer rating from the #ACGCRJ editorial board.  

Thank you,  Dr. Kagzi!

<a href="/NadeemYousafMD/">Nadeem Yousaf</a> <a href="/PrateekHarne1/">Prateek Harne MBBS, MD</a> <a href="/AmCollegeGastro/">ACG</a> 
#GITwitter #MedTwitter
Ahmed Telbany MD, MPH (@telbanymd) 's Twitter Profile Photo

Huge thanks to our ACGCRJ guest speaker Douglas G. Adler MD, FASGE, FACG, AGAF for sharing some seriously valuable insights and practical wisdom. We’re grateful for the time, the laughs, and the take-home pearls!

Huge thanks to our <a href="/ACGCRJ/">ACGCRJ</a> guest speaker <a href="/DouglasAdlerMD/">Douglas G. Adler MD, FASGE, FACG, AGAF</a> for sharing some seriously valuable insights and practical wisdom. We’re grateful for the time, the laughs, and the take-home pearls!
Edward Loftus (@edwardloftus2) 's Twitter Profile Photo

ACG Clinical Guideline: Management of Crohn's Disease in... : Official journal of the American College of Gastroenterology | ACG journals.lww.com/ajg/fulltext/2… Anita Afzali MD, MPH, MHCM, FACG, AGAF ACG

Patrick Young (@peyoungmd) 's Twitter Profile Photo

📣#DrCynthiaYoshida taking the mystery out of abdominal pressure during colonoscopy ACG #EndoscopySchool 👉🏻Right Place 👉🏻Right Time

📣#DrCynthiaYoshida taking the mystery out of abdominal pressure during colonoscopy <a href="/AmCollegeGastro/">ACG</a> #EndoscopySchool

👉🏻Right Place
👉🏻Right Time
Ray Dalio (@raydalio) 's Twitter Profile Photo

Make sure they're fully informed and believable. Find out who is responsible for whatever you are seeking to understand and then ask them. Listening to uninformed people is worse than having no answers at all. #principleoftheday

Make sure they're fully informed and believable. Find out who is responsible for whatever you are seeking to understand and then ask them. Listening to uninformed people is worse than having no answers at all.

#principleoftheday
Crohn's & Colitis Foundation (@crohnscolitisfn) 's Twitter Profile Photo

A huge thank you to our outgoing Editor-in-Chief, Miguel Regueiro, for his visionary leadership of Crohn’s & Colitis 360 over the last 7 years! We appreciate Miguel Regueiro's service & dedication to launching this open-access journal & helping it obtain the success it has today. 👏

A huge thank you to our outgoing Editor-in-Chief, <a href="/MRegueiroMD/">Miguel Regueiro</a>, for his visionary leadership of Crohn’s &amp; Colitis 360 over the last 7 years! We appreciate <a href="/MRegueiroMD/">Miguel Regueiro</a>'s service &amp; dedication to launching this open-access journal &amp; helping it obtain the success it has today. 👏
Governor Josh Shapiro (@governorshapiro) 's Twitter Profile Photo

Private equity has infected our health care system, forcing hospitals like Crozer to close and devastating the communities they serve. But we have the power to do something about it. My plan to stop private equity from gutting health care in Pennsylvania just passed the PA

GIE (@gie_journal) 's Twitter Profile Photo

Online now in GIE’s Articles in Press: "Clinical utility of incorporating next-generation sequencing results in the management algorithm of pancreatic cysts" by Alex R. Jones et al. giejournal.org/article/S0016-… #GITwitter

Online now in GIE’s Articles in Press: "Clinical utility of incorporating next-generation sequencing results in the management algorithm of pancreatic cysts" by Alex R. Jones et al. giejournal.org/article/S0016-…

#GITwitter
Nadeem Yousaf (@nadeemyousafmd) 's Twitter Profile Photo

Final board meeting of the term ACGCRJ Proud of this stellar team who set a new bar for excellence!🙌 ✅Achieved beyond their term🎯 🌟Reviewed record submissions ⏰Shorter decision time 📈 Boost journal visibility 🤝 Mentored with committees 🙏 ACG Prateek Harne MBBS, MD

Final board meeting of the term <a href="/ACGCRJ/">ACGCRJ</a> 
Proud of this stellar team who set a new bar for excellence!🙌
✅Achieved beyond their term🎯
🌟Reviewed record submissions
⏰Shorter decision time
📈 Boost journal visibility
🤝 Mentored with committees
🙏 <a href="/AmCollegeGastro/">ACG</a> <a href="/PrateekHarne1/">Prateek Harne MBBS, MD</a>
ACGCRJ (@acgcrj) 's Twitter Profile Photo

Introducing the 2025-2026 ACG Case Reports Journal Editorial Board! Editors-in-Chief Dr. Daniyal Abbas and Dr. Dushyant Dahiya (Daniyal Abbas & Dushyant Singh Dahiya, MD) are excited to collaborate with this year's talented Associate Editors. #GIfellows Meet them below! 👇

Introducing the 2025-2026 ACG Case Reports Journal Editorial Board!

Editors-in-Chief Dr. Daniyal Abbas and Dr. Dushyant Dahiya (<a href="/DaniyalAbbasMD/">Daniyal Abbas</a> &amp; <a href="/DushDahiya/">Dushyant Singh Dahiya, MD</a>) are excited to collaborate with this year's talented Associate Editors. #GIfellows 

Meet them below! 👇
Ahmed Telbany MD, MPH (@telbanymd) 's Twitter Profile Photo

Hard to believe my time on the ACGCRJ editorial board has officially wrapped up. It’s been an incredible ride full of learning, growth, and amazing people. Big congrats to the new 2025–2026 Associate Editors! You’re in for something special. #GIFellows

Michael Weintraub, MD (@mweintraubmd) 's Twitter Profile Photo

Yet another study showing high discontinuation rate of both semaglutide and tirzepatide up to 50% at 1 year in the real world. Top discontinuation reasons included: • Side effects (36%) • Logistical challenges (24%) • Cost (23%) • Shortages (11%) • Inadequate weight loss

Yet another study showing high discontinuation rate of both semaglutide and tirzepatide up to 50% at 1 year in the real world. 

Top discontinuation reasons included:
• Side effects (36%)
• Logistical challenges (24%)
• Cost (23%)
• Shortages (11%)
• Inadequate weight loss
Ahmed E Salem (@drahmedsalem2) 's Twitter Profile Photo

🚨 Just submitted my GI fellowship application! AAMC: 13407668 🩺💙 From Cairo to Brooklyn, from scoping bleeds to scoping journals, grateful for every patient, mentor. ✅ 100+ pubs 🏅 Hopkins Fellowship 💚 EB1A green card Now we wait... (with caffeine)😅☕️ #ERAS2025

🚨 Just submitted my GI fellowship application!
AAMC: 13407668 🩺💙

From Cairo to Brooklyn, from scoping bleeds to scoping journals, grateful for every patient, mentor.

✅ 100+ pubs
🏅 Hopkins Fellowship
💚 EB1A green card

Now we wait... (with caffeine)😅☕️
#ERAS2025